Regulatory T cells in a spectrum of HPV-induced cervical lesions: Cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma

American Journal of Reproductive Immunology

Volumn 60, Issue 1, 2008, Pages 55-65

  Adurthi, Sreenivas ^a   Krishna, Sudhir ^b   Mukherjee, Geetashree ^a   Bafna, Uttamchand Deepak ^a   Devi, Uma ^a   Jayshree, Rudrapatna Subramanyam ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

CD25+; CD4+; FOXP3+; Induced regulatory T cells; Natural regulatory T cells; TGFb

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VIRUS DNA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SQUAMOUS CELL CARCINOMA; STROMA; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA IN SITU; UTERUS CARCINOMA; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 45349093491     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00590.x     Document Type: Article

References (40)

1. zur Hausen H: Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999; 111:581-587.
2. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428.
3. zur Hausen H: PapillomaFiruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2:342-350.
4. Stanley M: Genital human papillomavirus infection-current and prospective therapies. J Natl Cancer Inst Monogr 2003; 31:117-124.
5. Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC: Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 2001; 167:2972-2978.
6. Dunn GP, Old LJ, Schreiber RD: The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22:329-360.
7. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T: Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: Their common role in controlling autoimmunity, tumor immunity and transplantation tolerance. Immunol Rev 2001; 182:18-32.
8. Picirrillo CA, Shevach EM: Naturally occurring CD4+CD25+ immunoregulatory T cells: Central players in the arena of peripheral tolerance. Semin Immunol 2004; 16:81-88.
9. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-336.
10. Piersma SJ, Jordanova ES, van Poelgeest MI, Kwappenberg KM, van der Hulst JM, Drijfhout JW, Melief CJ, Kenter GG, Fleuren GJ, Offringa R, van der Burg SH: High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. Cancer Res 2007; 67:354-361.
11. Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, Saito S: Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci 2007; 98:874-881.
12. Shi SR, Cote RJ, Wu L, Liu C, Datar R, Shi Y, Liu D, Lim H, Taylor CR: DNA extraction from archival formalin-fixed, paraffin-embedded tissue sections based on the antigen retrieval principle: Heating under the influence of pH. J Histochem Cytochem 2002; 50:1005-1011.
13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ: Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-361.
14. Marafioti T, Jones M, Facchetti F, Diss TC, Du MQ, Isaacson PG, Pozzobon M, Pileri SA, Strickson AJ, Tan SY, Watkins F, Mason DY: Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood 2003; 102:2868-2876.
15. Vigouroux S, Yvon E, Biagi E, Brenner MK: Antigen-induced regulatory T cells. Blood 2004; 104:26-33.
16. Chao HT, Wang PH, Tseng JY, Lai CR, Chiang SC, Yuan CC: Lymphocyte-infiltrated FIGO stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival. Eur J Gynaecol Oncol 1999; 20:136-140.
17. Evans EM, Man S, Evans AS, Borysiewicz LK: Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res 1997; 57:2943-2950.
18. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H: CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58:3491-3494.
19. Menon AG, Fleuren GJ, Alphenaar EA, Jonges LE, Janssen van Rhijn CM, Ensink NG, Putter H, Tollenaar RA, van de Velde CJ, Kuppen PJ: A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol Immunother 2003; 52:121-126.
20. Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB: Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004; 10:4450-4456.
21. Diederichsen AC, Hjelmborg JB, Christensen PB, Zeuthen J, Fenger C: Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 2003; 52:423-428.
22. Gey A, Kumari P, Sambandam A, Lecuru F, Cassard L, Badoual C, Fridman C, Nagarajan B, Fridman WH, Tartour E: Identification and characterisation of a group of cervical carcinoma patients with profound down regulation of intratumoral type 1 (IFN γ) and type 2 (IL 4) cytokine m RNA expression. Eur J Cancer 2003; 39:595-603.
23. Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL: Tumor infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol 2001; 81:424-432.
24. Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF: Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004; 20:107-118.
25. Terabe M, Berzofsky JA: Immunoregulatory T cells in tumor immunity. Curr Opin Immunol 2004; 16:157-162.
26. Wang RF: Immune suppression by tumor specific CD4+ regulatory T-cells in cancer. Semin Cancer Biol 2006; 16:73-79.
27. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10:942-949.
28. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH:RCutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002; 168:4272-4276.
29. Fattorossi A, Battaglia A, Ferrandina G, Buzzonetti A, Legge F, Salutari V, Scambia G: Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients. Gynecol Oncol 2004; 92:106-115.
30. Wolf D, Wolf AM, Rumpold H, Fiegl H, Zeimet AG, Muller-Holzner E, Deibl M, Gastl G, Gunsilius E, Marth C: The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005; 11:8326-8331.
31. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma following resection. J Clin Oncol 2007; 25:2586-2593.
32. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25-T cells. J Clin Invest 2003; 112:1437-1443.
33. Sakaguchi S, Ono M, Setoguchi R: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self tolerance and autoimmune diseases. Immunol Rev 2006; 212:8-27.
34. Mempel TR, Pittet MJ, Khazaie K, Weninger W, Weissleder R, von Boehmer H, von Andrian UH: Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 2006; 25:129-141.
35. Molling JW, de Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, van den Eertwegh AJ, Scheper RJ, von Blomberg ME, Bontkes HJ: CD4+CD25 hi regulatory T cell frequency correlates with persistence of human papillomavirus type 16 and helper cell responses in patients with cervical intraepithelial neoplasia. Int J Cancer 2007; 121:1749-1755.
36. Suffia I, Reckling SK, Salay G, Belkaid Y: A role for CD103 in the retention of CD4+CD25+ Tregs and control of Leishmania major infection. J Immunol 2005; 174:5444-5455.
37. Schreiber RD: Cancer vaccines 20T4 opening address: the molecular and cellular basis of cancer immunosurveillance and immunoediting. Cancer Immun 2005; 5(Suppl.):1-8.
38. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, ZinzindohouéF, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Pagès F: Type density and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-1964.
39. Almeida AR, Zaragoza B, Freitas AA: Indexation as a novel mechanism of lymphocyte homeostasis: The number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J Immunol 2006; 177:192-200.
40. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Bräuer R, Buer J, Scheffold A, Hamann A: Developmental stage, phenotype and migration distinguish naïve - and effector/memory like CD4+ regulatory T cells. J Exp Med 2004; 199:303-313.